SciBase Holding AB (publ), a medical technology company, develops and commercializes point-of-care platforms for skin health management in Europe, the United States, North America, Asia, Oceania, and internationally. It operates through Skin Cancer and Skin Barrier Assessment segments. The company offers Nevisense and Nevisense Go point-of-care platforms to detect melanoma and non-melanoma skin ca...
SciBase Holding AB (publ) reported revenue of 40.46 million SEK for fiscal year 2025, up 36.2% from fiscal year 2024, and net income of -87.06 million SEK. In Q2 2026 (the quarter ended June 30, 2026) revenue was 15.31 million SEK, up 74.1% from a year before.
Figures from company filings; latest fiscal year ended December 31, 2025.
No profile data available.